IDEXX Laboratories Inc
NASDAQ:IDXX

Watchlist Manager
IDEXX Laboratories Inc Logo
IDEXX Laboratories Inc
NASDAQ:IDXX
Watchlist
Price: 417.24 USD -0.31% Market Closed
Market Cap: 34.2B USD
Have any thoughts about
IDEXX Laboratories Inc?
Write Note

IDEXX Laboratories Inc
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

IDEXX Laboratories Inc
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
IDEXX Laboratories Inc
NASDAQ:IDXX
Other Current Liabilities
$38.4m
CAGR 3-Years
-23%
CAGR 5-Years
-11%
CAGR 10-Years
-2%
Becton Dickinson and Co
NYSE:BDX
Other Current Liabilities
$6.8B
CAGR 3-Years
238%
CAGR 5-Years
117%
CAGR 10-Years
67%
Boston Scientific Corp
NYSE:BSX
Other Current Liabilities
$1B
CAGR 3-Years
0%
CAGR 5-Years
5%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
Other Current Liabilities
$699m
CAGR 3-Years
5%
CAGR 5-Years
19%
CAGR 10-Years
3%
Abbott Laboratories
NYSE:ABT
Other Current Liabilities
$1.6B
CAGR 3-Years
10%
CAGR 5-Years
20%
CAGR 10-Years
-3%
Intuitive Surgical Inc
NASDAQ:ISRG
Other Current Liabilities
$590.6m
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
10%
No Stocks Found

IDEXX Laboratories Inc
Glance View

Market Cap
34.3B USD
Industry
Health Care

IDEXX Laboratories Inc. is a leading global provider of veterinary diagnostic products and services, dedicated to enhancing the health and well-being of pets worldwide. Founded in 1983, the company has established itself as an innovator in the animal healthcare market, offering a comprehensive range of diagnostic tests, equipment, and software that empower veterinarians to make informed decisions. With a consistent focus on research and development, IDEXX has expanded its portfolio to include cutting-edge solutions such as digital imaging and telemedicine, addressing the growing needs of the pet care industry. Their strategic partnerships and robust distribution channels further bolster their presence in both developed and emerging markets. For investors, IDEXX represents a compelling opportunity within a steadily growing sector. The company's recurring revenue model, driven by its suite of diagnostic tests and subscriptions to software solutions, ensures stable cash flow and predictability in earnings. IDEXX has also demonstrated impressive financial performance, characterized by strong revenue growth, high profit margins, and a commitment to shareholder returns. By harnessing trends in pet ownership and increasing expenditures on pet healthcare, IDEXX positions itself as a reliable player in the marketplace. With its dedication to innovation, customer service, and global expansion, IDEXX Laboratories Inc. stands poised for sustained growth, making it an attractive consideration for long-term investors.

IDXX Intrinsic Value
252.54 USD
Overvaluation 39%
Intrinsic Value
Price

See Also

What is IDEXX Laboratories Inc's Other Current Liabilities?
Other Current Liabilities
38.4m USD

Based on the financial report for Sep 30, 2024, IDEXX Laboratories Inc's Other Current Liabilities amounts to 38.4m USD.

What is IDEXX Laboratories Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
-2%

Over the last year, the Other Current Liabilities growth was -56%. The average annual Other Current Liabilities growth rates for IDEXX Laboratories Inc have been -23% over the past three years , -11% over the past five years , and -2% over the past ten years .

Back to Top